Kingsley Capital Partners

Kingsley Capital Partners LLP is a private equity and venture capital firm based in London, United Kingdom, with additional offices in Hong Kong, Istanbul, Santa Monica, Zürich, and Seoul. Founded in 2011, the firm specializes in growth equity and various investment strategies including acquisitions, shareholder liquidity, and management buyouts. Kingsley Capital focuses on sectors such as consumer and retail, healthcare and life sciences, industrial and business services, and technology, media, and telecommunications. The firm seeks to invest between £5 million and £200 million in equity, taking both minority and majority stakes, and often prefers to act as a sole or lead investor. It emphasizes a collaborative approach with management teams to generate strong risk-adjusted returns and may exit investments through public offerings, trade sales, or strategic mergers. With a strong backing from family offices and institutional investors, Kingsley Capital Partners leverages its extensive market research and industry relationships to support the growth of its partner companies.

Ciaran Canavan

Vice President and Principal

Markus Hepp

Managing Partner, Switzerland

Hee-Dong Kim

Co-Founder and Managing Partner

Neil Mahapatra

Managing Partner

Indraneil Mahapatra

Co-Founder and Managing Partner

Jakub Świeboda

Principal and Partner

6 past transactions

QuantifiedESG

Series A in 2022
QuantifiedESG is a company that specializes in developing assessment and rating tools focused on environmental, social, and governance (ESG) evaluations. Its platform quantitatively analyzes various social and environmental risk factors, producing detailed ESG evaluation reports. These reports assess the management of business and asset risks, allowing clients to evaluate the sustainability of their supply chains. By providing objective insights into ESG performance, QuantifiedESG supports businesses in making informed decisions regarding sustainable practices and risk management.

Spring Fibre

Seed Round in 2019
Spring Fibre is a London-based operator of fiber optics networks that specializes in providing wholesale fiber network solutions. The company focuses on developing robust infrastructure to facilitate high-speed internet access, particularly in underpenetrated and hard-to-reach areas. By enabling retailers to offer reliable broadband services, Spring Fibre aims to enhance connectivity and meet the growing demand for efficient internet solutions.

Atlas Tower Group

Seed Round in 2018
Atlas Tower Group is a wireless infrastructure solution provider focused on designing and constructing 5G-ready towers and rooftops. The company specializes in acquiring telecommunication sites and offers comprehensive installation and integration services for active infrastructure. By addressing the needs of multiple tenants, Atlas Tower Group enables mobile network operators to meet the increasing demand for coverage and capacity, thereby enhancing connectivity in various regions.

Equinox International

Seed Round in 2018
Equinox International is a cannabis company that specializes in the development of pharmaceutical quality products. It operates as a vertically integrated land-to-brand entity, focusing on a diverse array of medical cannabis offerings. The company provides a wide selection of products including cannabis oil, tinctures, tonics, tablets, capsules, and topical creams and lotions. This product range is designed to meet various therapeutic needs and personal preferences, ensuring that clients can find suitable options for specific indications and lifestyles.

Oxford Cannabinoid Technologies

Venture Round in 2017
Oxford Cannabinoid Technologies Ltd., established in 2017 and based in Oxford, UK, is a biopharmaceutical company dedicated to researching, developing, and licensing cannabinoid-based compounds and therapies. Its primary focus lies in creating novel treatments for diseases with high unmet medical need, combining cannabinoid medicine with world-class scientific research and drug development. The company's therapeutic areas of interest include inflammatory diseases, oncology, neurological disorders, and pain management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.